SEC Form 4 · accession 0001232524-18-000196
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Seamus Mulligan
Director
Period of report
Nov 15, 2018
Accepted (ET)
Nov 19, 2018 · 5:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Nov 15, 2018 | P | 300 | $141.8633 | A | 1,051,168 | D | |
| Ordinary SharesF2 | Nov 15, 2018 | P | 1,200 | $143.2242 | A | 1,052,368 | D | |
| Ordinary SharesF3 | Nov 15, 2018 | P | 26,363 | $144.2431 | A | 1,078,731 | D | |
| Ordinary SharesF4 | Nov 15, 2018 | P | 22,137 | $145.0464 | A | 1,100,868 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $141.52 to $142.04. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.
- F2Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $142.67 to $143.60. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.
- F3Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $143.69 to $144.67. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.
- F4Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $144.69 to $145.56. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.